|3.65||+0.01 / +0.27%|
Data as of 3:59pm ET
|3.65||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +64.38% increase from the last price of 3.65.
The current consensus among 3 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.